Nardev S. Khurmi - Researcher Profile

Publications

3 shown

Baseline Characteristics of Participants in the JUPITER Trial, A Randomized Placebo-Controlled Primary Prevention Trial of Statin Therapy Among Individuals With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein

Paul M. Ridker , Francisco Antônio Helfenstein Fonseca , Jacques Genest +10 more

2007 The American Journal of Cardiology 125 citations

The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme. Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease

Salim Yusuf , S Mehta , Shuchi Anand +95 more

Randomized trials of thienopyridines in patients with vascular disease demonstrate that thienopyridines are effective in reducing vascular events when compared with placebo/cont...

2000 European Heart Journal 299 citations

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials

Naveed Sattar , Matthew M.Y. Lee , Søren Lund Kristensen +9 more

2021 The Lancet Diabetes & Endocrinology 1304 citations

Frequent Co-Authors

Researcher Info

h-index: 3
Publications: 3
Citations: 1,728
Institution: AstraZeneca (United States)

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0003-3677-6356

Impact Metrics

h-index 3

h-index: Number of publications with at least h citations each.